Kidney360 now discoverable in PMC!
We are proud to announce that Kidney360 has passed the rigorous review process for acceptance into PMC. All content is now available and indexed in PMC.
SEVEN MOST RECENTLY PUBLISHED
- You have accessRestricted AccessAssociations of Anxiety during the COVID-19 Pandemic with Patient Characteristics and Behaviors in CKD Patients: Findings from the Chronic Renal Insufficiency Cohort (CRIC) StudyKidney360 May 2022, 10.34067/KID.0000222022; DOI: https://doi.org/10.34067/KID.0000222022
- You have accessRestricted AccessGlobal Dialysis Perspective: EthiopiaKidney360 May 2022, 10.34067/KID.0006902021; DOI: https://doi.org/10.34067/KID.0006902021
- You have accessRestricted AccessCounty-Level Dialysis Facility Supply and Distance Traveled to Facilities Among Incident Kidney Failure PatientsKidney360 May 2022, 10.34067/KID.0000312022; DOI: https://doi.org/10.34067/KID.0000312022
- You have accessRestricted AccessClinical, pathological, and genetic characteristics in patients with focal segmental glomerulosclerosisKidney360 May 2022, 10.34067/KID.0000812022; DOI: https://doi.org/10.34067/KID.0000812022
- You have accessRestricted AccessEffects of Short-Term Potassium Chloride Supplementation in Patients with Chronic Kidney DiseaseJASN May 2022, ASN.2022020147; DOI: https://doi.org/10.1681/ASN.2022020147
- You have accessRestricted AccessAlbuminuria-Lowering Effect of Dapagliflozin, Eplerenone, and their Combination in Patients with Chronic Kidney Disease: A Randomized Cross-Over Clinical TrialJASN May 2022, ASN.2022020207; DOI: https://doi.org/10.1681/ASN.2022020207
- You have accessRestricted AccessEndothelin Receptor Antagonists for Kidney ProtectionCJASN May 2022, CJN.00560122; DOI: https://doi.org/10.2215/CJN.00560122
Podcast
Editorial and Training Opportunities
- JASN has a robust Editorial Fellowship program. Learn more about the program: JASN Fellowship
- CJASN has a strong Trainee program for first-time first authors. Learn more about the program: CJASN Trainee
- The Kidney360 Training Program for early-career nephrologists and scientists is an editorial mentorship program. Learn more at: Training Opportunities
CJASN Podcast: Apolipoprotein L1 High-Risk Genotypes and Albuminuria in Sub-Saharan African Populations